NRAS Mutations in Cancer: Gene Function, Oncogenic Signaling, and Clinically Relevant Variants
NRAS (neuroblastoma RAS viral oncogene homolog) is one of the three members of the RAS proto-oncogene family, together with HRAS and KRAS. It encodes a small GTPase protein with a molecular weight of approximately 21 kDa, which plays a central role in transmitting signaling pathways involved in cell proliferation, differentiation, and survival. RAS family genes represent some of the most frequently mutated oncogenes in human cancers. Comprehensive analyses estimate that approximately 19% of cancer patients harbor mutations in at least one RAS gene, with KRAS mutations being the most prevalent, followed by NRAS and HRAS mutations. Compared with KRAS, NRAS mutations exhibit a more restricted distribution among specific tumor types, with particularly high frequencies observed in melanoma, multiple myeloma, and acute myeloid leukemia (AML). NRAS mutations typically result in constitutive activation of the N-Ras protein, leading to persistent activation of key downstream signaling pathways,...